Table of Contents Brazil End-Stage Kidney Disease Treatment Market Research Report 2018 1 End-Stage Kidney Disease Treatment Overview 1.1 Product Overview and Scope of End-Stage Kidney Disease Treatment 1.2 Classification of End-Stage Kidney Disease Treatment by Product Category 1.2.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Comparison by Type (2013-2025) 1.2.2 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Market Share by Type in 2017 1.2.3 MK-3866 1.2.4 Pacritinib 1.2.5 Sanguinate 1.2.6 Tesidolumab 1.2.7 Others 1.3 Brazil End-Stage Kidney Disease Treatment Market by Application/End Users 1.3.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Market Share Comparison by Application (2013-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Brazil Revenue and Sales of End-Stage Kidney Disease Treatment (2013-2025) 1.4.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2025) 1.4.2 Brazil End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025) 2 Brazil End-Stage Kidney Disease Treatment Market Competition by Players/Manufacturers 2.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018) 2.2 Brazil End-Stage Kidney Disease Treatment Revenue and Share by Players/Manufacturers (2013-2018) 2.3 Brazil End-Stage Kidney Disease Treatment Average Price (USD/Pcs) by Players/Manufacturers (2013-2018) 2.4 Brazil End-Stage Kidney Disease Treatment Market Competitive Situation and Trends 2.4.1 Brazil End-Stage Kidney Disease Treatment Market Concentration Rate 2.4.2 Brazil End-Stage Kidney Disease Treatment Market Share of Top 3 and Top 5 Players/Manufacturers 2.4.3 Mergers & Acquisitions, Expansion in Brazil Market 2.5 Brazil Players/Manufacturers End-Stage Kidney Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type 3 Brazil End-Stage Kidney Disease Treatment Sales and Revenue (Value) by Type (2013-2018) 3.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018) 3.2 Brazil End-Stage Kidney Disease Treatment Revenue (Million USD) and Market Share by Type (2013-2018) 3.3 Brazil End-Stage Kidney Disease Treatment Price (USD/Pcs) by Type (2013-2018) 3.4 Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (%) by Type (2013-2018) 4 Brazil End-Stage Kidney Disease Treatment Sales by Application (2013-2018) 4.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Market Share by Application (2013-2018) 4.2 Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (%) by Application (2013-2018) 4.3 Market Drivers and Opportunities 5 Brazil End-Stage Kidney Disease Treatment Players/Suppliers Profiles and Sales Data 5.1 BLR Bio LLC 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.1.2.1 Product A 5.1.2.2 Product B 5.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.1.4 Main Business/Business Overview 5.2 CTI BioPharma Corp 5.2.1 Company Basic Information, Manufacturing Base and Competitors 5.2.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.2.2.1 Product A 5.2.2.2 Product B 5.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.2.4 Main Business/Business Overview 5.3 F. Hoffmann-La Roche Ltd 5.3.1 Company Basic Information, Manufacturing Base and Competitors 5.3.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.3.2.1 Product A 5.3.2.2 Product B 5.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.3.4 Main Business/Business Overview 5.4 Novartis AG 5.4.1 Company Basic Information, Manufacturing Base and Competitors 5.4.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.4.2.1 Product A 5.4.2.2 Product B 5.4.3 Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.4.4 Main Business/Business Overview 5.5 Prolong Pharmaceuticals LLC 5.5.1 Company Basic Information, Manufacturing Base and Competitors 5.5.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.5.2.1 Product A 5.5.2.2 Product B 5.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.5.4 Main Business/Business Overview 5.6 VESSL Therapeutics Ltd 5.6.1 Company Basic Information, Manufacturing Base and Competitors 5.6.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification 5.6.2.1 Product A 5.6.2.2 Product B 5.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 5.6.4 Main Business/Business Overview ... 6 End-Stage Kidney Disease Treatment Manufacturing Cost Analysis 6.1 End-Stage Kidney Disease Treatment Key Raw Materials Analysis 6.1.1 Key Raw Materials 6.1.2 Price Trend of Key Raw Materials 6.1.3 Key Suppliers of Raw Materials 6.1.4 Market Concentration Rate of Raw Materials 6.2 Proportion of Manufacturing Cost Structure 6.2.1 Raw Materials 6.2.2 Labor Cost 6.2.3 Manufacturing Expenses 6.3 Manufacturing Process Analysis of End-Stage Kidney Disease Treatment 7 Industrial Chain, Sourcing Strategy and Downstream Buyers 7.1 End-Stage Kidney Disease Treatment Industrial Chain Analysis 7.2 Upstream Raw Materials Sourcing 7.3 Raw Materials Sources of End-Stage Kidney Disease Treatment Major Manufacturers in 2017 7.4 Downstream Buyers 8 Marketing Strategy Analysis, Distributors/Traders 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Market Positioning 8.2.1 Pricing Strategy 8.2.2 Brand Strategy 8.2.3 Target Client 8.3 Distributors/Traders List 9 Market Effect Factors Analysis 9.1 Technology Progress/Risk 9.1.1 Substitutes Threat 9.1.2 Technology Progress in Related Industry 9.2 Consumer Needs/Customer Preference Change 9.3 Economic/Political Environmental Change 10 Brazil End-Stage Kidney Disease Treatment Market Size (Sales and Revenue) Forecast (2018-2025) 10.1 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025) 10.2 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Type (2018-2025) 10.3 Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Application (2018-2025) 11 Research Findings and Conclusion

List of Tables and Figures Figure Brazil Market Size (Million USD) Status and Outlook (2013-2025) Table End-Stage Kidney Disease Treatment Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type Table End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2017-2025) Figure Product Picture of End-Stage Kidney Disease Treatment Table Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025) Figure Brazil End-Stage Kidney Disease Treatment Sales Volume Market Share by Type in 2017 Figure MK-3866 Product Picture Figure Pacritinib Product Picture Figure Sanguinate Product Picture Figure Tesidolumab Product Picture Figure Others Product Picture Figure Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Comparison by Application (2013-2025) Figure Brazil Sales Market Share (%) of End-Stage Kidney Disease Treatment by Application in 2017 Figure Clinic Examples Figure Hospital Examples Figure Others Examples Figure Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2025) Figure Brazil End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (%)(2013-2025) Table Brazil End-Stage Kidney Disease Treatment Sales of Key Players/Manufacturers (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Sales Share (%) by Players/Manufacturers (2013-2018) Figure 2017 Brazil End-Stage Kidney Disease Treatment Sales Share (%) by Players/Manufacturers Figure 2017 Brazil End-Stage Kidney Disease Treatment Sales Share (%) by Players/Manufacturers Table Brazil End-Stage Kidney Disease Treatment Revenue by Players/Manufacturers (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Revenue Market Share (%) by Players/Manufacturers (2013-2018) Figure 2017 Brazil End-Stage Kidney Disease Treatment Revenue Share (%) by Players/Manufacturers Figure 2017 Brazil End-Stage Kidney Disease Treatment Revenue Share (%) by Players/Manufacturers Table Brazil Market End-Stage Kidney Disease Treatment Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018) Figure Brazil Market End-Stage Kidney Disease Treatment Average Price (USD/Pcs) of Key Players/Manufacturers in 2017 Figure Brazil End-Stage Kidney Disease Treatment Market Share of Top 3 Players/Manufacturers Figure Brazil End-Stage Kidney Disease Treatment Market Share of Top 5 Players/Manufacturers Table Brazil Players/Manufacturers End-Stage Kidney Disease Treatment Manufacturing Base Distribution and Sales Area Table Brazil Players/Manufacturers End-Stage Kidney Disease Treatment Product Category Table Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Sales Share (%) by Type (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Share (%) by Type (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Market Share (%) by Type in 2017 Table Brazil End-Stage Kidney Disease Treatment Revenue (Million USD) and Market Share by Type (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Revenue Market Share (%) by Type (2013-2018) Figure Revenue Market Share of End-Stage Kidney Disease Treatment by Type (2013-2018) Figure Revenue Market Share of End-Stage Kidney Disease Treatment by Type in 2017 Table Brazil End-Stage Kidney Disease Treatment Price (USD/Pcs) by Type (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (%) by Type (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2013-2018) Table Brazil End-Stage Kidney Disease Treatment Sales Market Share (%) by Application (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Market Share (%) by Application (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Market Share (%) by Application in 2017 Table Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (%) by Application (2013-2018) Figure Brazil End-Stage Kidney Disease Treatment Sales Growth Rate (%) by Application (2013-2018) Table BLR Bio LLC End-Stage Kidney Disease Treatment Basic Information List Table BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure BLR Bio LLC End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure BLR Bio LLC End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Basic Information List Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Basic Information List Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table Novartis AG End-Stage Kidney Disease Treatment Basic Information List Table Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Novartis AG End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure Novartis AG End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Basic Information List Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Basic Information List Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales Market Share (%) in Brazil (2013-2018) Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue Market Share (%) in Brazil (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of End-Stage Kidney Disease Treatment Figure Manufacturing Process Analysis of End-Stage Kidney Disease Treatment Figure End-Stage Kidney Disease Treatment Industrial Chain Analysis Table Raw Materials Sources of End-Stage Kidney Disease Treatment Major Players/Manufacturers in 2017 Table Major Buyers of End-Stage Kidney Disease Treatment Table Distributors/Traders List Figure Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend Forecast (2018-2025) Table Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Type (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Type (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Sales Volume Market Share Forecast by Type in 2025 Table Brazil End-Stage Kidney Disease Treatment Sales (K Pcs) Forecast by Application (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Sales Volume Market Share Forecast by Application (2018-2025) Figure Brazil End-Stage Kidney Disease Treatment Sales Volume Market Share Forecast by Application in 2025